HEALTH● LOWJun 26 · Jun 26, 2026, 6:40 PM
China Approves CARsgen’s CAR-T Treatment for Stomach Cancer
Human Progress
“China’s drug regulator said on Monday it has approved a CARsgen Therapeutics treatment for stomach cancer, a new milestone for CAR-T therapies, which engineer patients’ immune cells to recognise and kill cancer cells. The injection, also known as satri-cel, is globally the first approved CAR-T cell therapy for solid tumors, CARsgen CEO Li Zonghai told […] The post China Approves CARsgen’s CAR-T Treatment for Stomach Cancer appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH40m agoNAFDAC orders recall of sachet alcohol drinks below 200mlVanguard NigeriaHEALTH54m agoLucía Kazelian, cardiologist: "Cardiovascular disease in women is not the same as in men"ClarínHEALTH1h agoRed hexagon on your snack pack: What FSSAI’s new proposed warning label means | ExplainedThe HinduHEALTH3h agoRotten meat, spoiled milk seized across Bengal as food safety raids widenThe Hindu